Patents by Inventor Winston A. Salser

Winston A. Salser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 6239171
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiathermogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: May 29, 2001
    Assignee: Lipogenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 6204290
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: March 20, 2001
    Assignee: Lipogenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 6143770
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: November 7, 2000
    Assignee: Lipogenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 5919818
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: July 6, 1999
    Assignee: Lipogenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 5821264
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: October 13, 1998
    Assignee: LipoGenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Tocotrienols and tocotrienol-like compounds and methods for their use
    Patent number: 5591772
    Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: January 7, 1997
    Assignee: Lipogenics, Inc.
    Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
  • Gene transfer in intact mammals
    Patent number: 4497796
    Abstract: Methods and compositions are provided for gene transfer to intact mammals with expression of the exogenous genetic material in the host. Mammalian host cells which are regenerative, normally highly proliferative or subject to induced proliferation, are transformed or modified in vitro with DNA capable of replication and expression in the host cell, wherein the DNA becomes incorporated into the cell. The modified cells are found to regenerate in the host with expression of the introduced DNA. Particularly, mammalian cells were modified with genes providing for overproduction of a particular enzyme. The modified cells were reintroduced in the host under conditions providing for selective advantage of the modified cells.
    Type: Grant
    Filed: December 8, 1982
    Date of Patent: February 5, 1985
    Assignee: The Regents of the University of California
    Inventors: Winston A. Salser, Martin J. Cline, Howard D. Stang
  • Gene transfer in intact mammals
    Patent number: 4396601
    Abstract: Methods and compositions are provided for gene transfer to intact mammals with expression of the exogenous genetic material in the host. Mammalian host cells which are regenerative, normally highly proliferative or subject to induced proliferation, are transformed or modified in vitro with DNA capable of replication and expression in the host cell, wherein the DNA becomes incorporated into the cell. The modified cells are found to regenerate in the host with expression of the introduced DNA. Particularly, mammalian cells were modified with genes providing for overproduction of a particular enzyme. The modified cells were reintroduced in the host under conditions providing for selective advantage of the modified cells.
    Type: Grant
    Filed: March 26, 1980
    Date of Patent: August 2, 1983
    Assignee: The Regents of the University of Calif.
    Inventors: Winston A. Salser, Martin J. Cline, Howard D. Stang